Navigation Links
Ovarian function and fertility preserved in women with severe systemic lupus erythematosus
Date:6/12/2008

for a median time of 24 months and 22 patients received 5-7 monthly 1g/m2 IV CYC pulses, followed by 2g/day MMF for a median time of 32 months (group B).

Results showed that disease activity was equally controlled using either treatment regimen (p=0.76 and p=0.31 for disease remission and relapse respectively), although patients in group A had a 4-fold higher risk of developing amenorrhea (absence of menstruation) compared with those in group B (p=0.001). 56% (n=22) of women in group A and 14% (n=3) in group B developed amenorrhea, while sustained amenorrhea developed in 51% (n=20/39) of women in group A vs 4% (n=1) in group B. 14% (3/22) of women in group A and 67% (2/3) in group B resumed menstruation following cessation of therapy.

Age (p<0.001), cumulative CYC dose (p=0.001) and anti-Ro antibodies (p=0.002) were significant in terms of amenorrhea. Sustained amenorrhea was related to both the form of treatment (p=0.006) and the age of the patients (p=0.026). The median total CYC dose until amenorrhea was 11 gr (range 2-29.5) and 3.7 gr (range 2-6.75) in group A and B respectively (p=0.036).

The median age of women with amenorrhea was 36 years (range 19-46) in group A and 33 years (range 27-45) in group B (p=0.71). It is of note that all patients aged >31 years developed amenorrhea with the long course CYC treatment and 94% did not resume menses until the end of follow up, whereas only 1 patient aged 45 years developed permanent amenorrhea with the short course CYC treatment.

SLE disease duration and ECLAM (European Consensus Lupus Activity Measurement) score were not significantly different in terms of amenorrhea (p≥0.05).


'/>"/>

Contact: Rory Berrie / Camilla Dormer
eularpressoffice@uk.cohnwolfe.com
44-077-892-70392
European League Against Rheumatism
Source:Eurekalert

Page: 1 2

Related medicine news :

1. A Knock-Out Match: Kelly Ripa and Molly Sims Team Up to Fight Ovarian Cancer
2. Coveting the Latest Clutch? Bid on a Bag and Help Fight Ovarian Cancer
3. Seattle-Based Marsha Rivkin Center for Ovarian Cancer Research Appoints Nancy Sclater, Executive Director
4. Stored Ovarian Tissue Needs Testing Before Re-Implantation
5. Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
6. Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
7. FASgen Diagnostic Tests Identify Ovarian Cancer Progression and Apoptosis
8. Specialized Care for Ovarian Cancer Improves Outcomes
9. Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers
10. Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
11. Gleevec May Disrupt Ovarian Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 The nation’s first trial ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) is now underway in California Superior ... opening statements were presented on May 28th, with ... the Profemur hip replacement made the device brittle ... just three years after it had been implanted ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as ... the latest and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... a person. , According to Psychology Today, humans are a ... explain that curiosity is a part of human development. People ...
(Date:6/2/2015)... Milton Hershey School® graduate Vincent Klomps ’10 ... of the Physician Assistant Program’s entering class of 2015 ... with a white coat, which symbolizes his entrance into ... of Vincent’s accomplishments both at MHS and postgraduation,” said ... of how a top-notch education can lead to achievement ...
(Date:6/2/2015)... Erbelli’s Gourmet Pizzeria, Italian Bistro & Pub ... gourmet pizzas and calzones, fresh wraps, submarine sandwiches, and ... the recipes are not—they have been satisfying the taste ... the site is the menu, which is broken up ... the items. You can order directly from the website ...
(Date:6/2/2015)... 02, 2015 IMPAK Corporation, a ... has announced the availability of “child-resistant” pouches and ... by children, especially curious toddlers. The Child Resistant ... tested to CFR 1700.20 protocols. The announcement was ... Looks Like Candy, “With the proliferation of consumer ...
Breaking Medicine News(10 mins):Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2
... , Republican Congressman Slated to ... h and Insurance Campaign Contributions , , ... conflict of interest questions about Rep. Charles Boustany (R-La.) and the ... Barack Obama,s speech to a joint session of Congress on health ...
... , , KEYSTONE TREATMENT AND OUTREACH ... SIMILAR EVENTS TO FOLLOW AT CANTON AT 1 PM: , KEYSTONE ... Media welcome at both locations , , SIOUX FALLS ... Falls, S.D. will be the 2009 national headquarters at 11 AM Wednesday, September ...
... , , , ... LLC, a leading infant formula company, has introduced Bright Beginnings(R) ... Beginnings(R) NeoCare(TM) is a milk-based infant formula intended to meet ... hospital discharge. , , Clinical evidence suggests ...
... produces mild infection, but severe reactions can result , WEDNESDAY, ... has been infected with the West Nile virus, whether they ... since the virus first appeared in North America in 1999, ... journal Emerging Infectious Diseases . , Several West Nile ...
... Industries Ltd. (NYSE: NBR ) invites you to join Eugene M. Isenberg, Chairman and ... third quarter 2009. Nabors will release earnings after the market closes on October 20, 2009. , ... October 21, 2009, Time: ... a.m. ET), Dial-in-number:, Domestic: ...
... , , LEWISTON, Maine and ... presenting sponsor of The Dempsey Challenge: A Journey for Hope, a cycling ... event supports The Patrick Dempsey Center for Cancer Hope & Healing at ... provides an opportunity to expand Amgen,s Breakaway from Cancer ((R)) ...
Cached Medicine News:Health News:Rep. Boustany Hauled in $1.25 Million From Health and Insurance Industry 2Health News:Wed., Sept. 16, 11 AM News Conference: Sioux Falls' Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Celebrating Recovery Against New Wave of Drug Abuse; Former U.S. Drug Czar/4-Star Gen. Barry McCaffrey, Lieute 2Health News:Bright Beginnings(R) NeoCare(TM) Value-Priced Weight Gain Infant Formula Now Available Online at www.pbmstore.com 2Health News:Study Shows 1% of Americans Have Been Infected With West Nile 2Health News:Study Shows 1% of Americans Have Been Infected With West Nile 3Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 2Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 3Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 4
(Date:6/2/2015)... June 2, 2015  Psychemedics Corporation (NASDAQ: PMD ... twenty-five years, announced the addition of 2 new drugs ... growing abuse concerns, the addition of Oxymorphone was made ... added as an option to the Amphetamine panel. ... stated:  "Sadly, more and more prescription drugs are being ...
(Date:6/2/2015)... , June 02, 2015 Research ... addition of the "Motion Simulation Market by ... DOF, Three DOF, and Six DOF), Application (Automotive, ... and Region - Forecast to 2020 " ... simulation is considered to have matured enough for ...
(Date:6/2/2015)... 2, 2015  Lannett Company, Inc. (NYSE: ... the acquisition of privately held, Silarx Pharmaceuticals, Inc. ... a manufacturer and marketer of liquid generic pharmaceutical ... to acquire Silarx on May 15, 2015.   ... evaluating a number of potential acquisitions, we are ...
Breaking Medicine Technology:Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3Global Motion Simulation Market 2015-2020 - Type, Degree of Freedom, Application, and Regional Analysis 2Lannett Completes Acquisition Of Silarx Pharmaceuticals, Inc. 2
... NEW YORK, Oct. 19 Reportlinker.com announces ... available in its catalogue: ... Pharmaceutical Market in China: Growth strategies, performance ... http://www.reportlinker.com/p0315841/The-Top-10-Companies-in-the-Hospital-Pharmaceutical-Market-in-China-Growth-strategies-performance-and-SWOT-analyses.html China is currently ...
... Reportlinker.com announces that a new market ... Triple Analysis: Apoptosis, Angiogenesis ... http://www.reportlinker.com/p0284949/Triple-Analysis-Apoptosis-Angiogenesis-and-Protein-Kinase-Inhibitors.html This triple ... by mechanism/target/effect of Apoptosis, Angiogenesis and Protein ...
Cached Medicine Technology:Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 2Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 3Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 4Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 5Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 6Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 7Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 8Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 9Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 2Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 3Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 4Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 5
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... The Ulti-Mist™ HME product line has ... from pediatrics to adults and from intubated ... offer superior humidification for both anesthesia and ... and HME/Filters provide maximum protection for patients ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
Medicine Products: